IP Library Granted Patent US 9,526,268
Granted Patent B2
US 9,526,268 · App. 14/670,935 · Granted Dec 27, 2016

Edible energy composition with low caffeine

Inventor: Manoj Bhargava (Farmington Hills, MI)
Assignee: International IP Holdings LLC
A23L1/296A23L2/38A23L2/52A23L2/56A23L27/00A23L33/15A23L33/175A23L33/40A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,268
App. No.
14/670,935
Granted
Dec 27, 2016
Kind
B2
Abstract

An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, enzymes, preservatives, and the like.

Claims (24)

1. A low-caffeine edible energy composition consisting of:

caffeine in an amount from about 0.00008 g/ml to about 0.0004 g/ml;

a choline derivative in an amount from about 0.0004 g/ml to about 0.009 g/ml;

a vitamin selected the group consisting of vitamin B6, vitamin B12;

folic acid and combinations thereof;

glucuronolactone;

an amino acid selected from the group consisting of N-acetyl L-tyrosine and L-phenylalanine and combinations thereof;

taurine;

an acidulant selected from the group consisting malic acid, citric acid and combination thereof;

sucralose;

and at least one preservative selected from the group consisting of benzoic acid derivatives, sorbic acid derivatives, EDTA and combinations thereof.

2. The energy composition of claim 1 wherein said caffeine is present in an amount from about 0.0001 g/ml to about 0.0003 g/ml.

3. The energy composition of claim 1 wherein said choline derivative is present in an amount from about 0.0008 g/ml to about 0.007 g/ml.

4. The energy composition of claim 1 wherein said choline derivative is present in an amount from about 0.001 g/ml to about 0.005 g/ml.

5. The energy composition of claim 1 wherein said choline derivative comprises citicoline.

6. The energy composition of claim 1 wherein said choline derivative comprises choline citrate.

7. The energy composition of claim 1 wherein said N-acetyl L-tyrosine is present in an amount from about 0.001 to about 0.01 g/mi.

8. The energy composition of claim 1 wherein said L-phenylalanine is present in an amount from about 0.001 to about 0.008 g/ml.

9. The energy composition of claim 1 wherein said taurine is present in an amount from about 0.002 to about 0.016 g/ml.

10. The energy composition of claim 1 wherein said glucuronolactone is present in an amount from about 0.001 to about 0.012 g/ml.

11. The energy composition of claim 1 wherein said folic acid is present in an amount from about 0.001 to about 0.0002 g/ml.

12. The energy composition of claim 1 wherein said vitamin B6 is present in an amount from about 0.0003 to about 0.001 g/ml.

13. The energy composition of claim 1 wherein said vitamin B12 is present in an amount from about 0.000001 to about 0.00003 g/ml.

14. The energy composition of claim 1 wherein said preservative is sodium benzoate, potassium sorbate and EDTA.

Assignments (5)
SECURITY INTEREST Recorded Feb 23, 2023
From: INTERNATIONAL IP HOLDINGS, LLC
To: BMO HARRIS BANK N.A., AS AGENT
Reel/Frame 062778/0478 →
RELEASE OF SECURITY INTEREST Recorded Feb 23, 2023
From: KEYBANK NATIONAL ASSOCIATOIN, AS AGENT
To: INTERNATIONAL IP HOLDINGS, LLC
Reel/Frame 062783/0252 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 14, 2016
From: INTERNATIONAL IP HOLDINGS, LLC
To: KEYBANK NATIONAL ASSOCIATION
Reel/Frame 040312/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2016
From: BHARGAVA, MANOJ
To: BIO CLINICAL DEVELOPMENT, INC
Reel/Frame 037737/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2016
From: BIO CLINICAL DEVELOPMENT, INC
To: INTERNATIONAL IP HOLDINGS LLC
Reel/Frame 037738/0315 →
Continuity (3)
Continuation 12742778
Provisional Application 60988599 · Nov 16, 2007
Related Publication 20150196047A1 · Jul 16, 2015